Moderate to Severe Atopic Dermatitis: Targeted Pathways and Strategies to Personalize Patient Care

Download All
Gain expert insights on personalizing care for patients with moderate to severe AD, including choosing among current treatment options, understanding emerging therapies, and recommending vaccinations for patients receiving immunosuppressants and immunomodulatory therapies for AD.
Sarah Lant, PharmD
Jamie L. McConaha, PharmD, NCTTP, BCACP, CDCES

Downloadable Slideset

Gain expert insights on personalizing care for patients with moderate to severe AD, including choosing among current treatment options, understanding emerging therapies, and recommending vaccinations for patients receiving immunosuppressants and immunomodulatory therapies for AD.

Sarah Lant, PharmD Jamie L. McConaha, PharmD, NCTTP, BCACP, CDCES Released: May 18, 2022

ClinicalThought

What is the pharmacist’s role in shared decision-making when choosing the optimal therapy for patients with atopic dermatitis? Here’s my take.

Jamie L. McConaha, PharmD, NCTTP, BCACP, CDCES Released: June 1, 2022
Provided by ProCE, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Incyte Corporation

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings